PPARG and Right ventricular hypertrophy: However, PPAR-mediated responses alone may not explain the observed effects, as treatment of hypoxia-exposed mice with the PPARγ agonist rosiglitazone attenuates rather than promotes the increase in pulmonary artery pressure and right ventricular hypertrophy [40].